President & CEO

Gail Maderis is President & CEO of BayBio and is a consultant for Five Prime Therapeutics, Inc., a privately held protein therapeutics company. From 2003 to 2009, Ms. Maderis served as FivePrime’s President and CEO, successfully funding the company’s rapid growth through substantial private equity financings and corporate partnerships. Prior to FivePrime, Ms. Maderis held senior executive positions at Genzyme Corporation, including founder and president of Genzyme Molecular Oncology (GZMO). Ms. Maderis practiced management and strategy consulting with Bain & Co. She serves on the boards of FivePrime, Trinity Biosystems, BayBio, the Mayor’s Biotech Advisory Council of San Francisco and the HBS Healthcare Initiative. She received a BS in business from the UC Berkeley and an MBA from Harvard Business School.

You can reach Ms. Maderis by clicking here.